Answer
Trabectedin (Yondelis) is indicated for adults with advanced soft tissue sarcoma after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents; efficacy data are based mainly on patients with liposarcoma and leiomyosarcoma.
Sources for this answer
- Yondelis 0.25 mg powder for concentrate for solution for infusionImmedica · emc · SmPC §4.1 Therapeutic Indications · Version 23Document updated
Sources checked